Statistics
Publications
30
Citations
2.3K
H-Index
23
Active since
1981
Daniel H. Johnson is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, immunotherapy, and checkpoint inhibitor therapy.
Publications per year
1981–2024
30
30
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 344 citations · Full text
Medicine, Immunology, Oncology +14
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao et al. · Inflammatory Bowel Diseases · 2018 · 244 citations
Daniel H. Johnson, Chrystia M. Zobniw, Van Anh Trinh et al. · Journal for ImmunoTherapy of Cancer · 2018 · 192 citations · Full text
1–5 of 30